Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | IGHV4-31///IGHV@///IGHM///IGHG1///IGHD///IGHA1 |
| Upstream (Parents) |
|---|
| (<<) LOC440871///IGK@///IGKV3-20///IGKV3D-11///IGKV3D-15///IGKC → IGHV4-31///IGHV@///IGHM///IGHG1///IGHD///IGHA1 |
| (<<) IGKV4-1 → IGHV4-31///IGHV@///IGHM///IGHG1///IGHD///IGHA1 |
| Downstream (Children) |
|---|
| IGHV4-31///IGHV@///IGHM///IGHG1///IGHD///IGHA1 → SFRP1 (>>) |
| IGHV4-31///IGHV@///IGHM///IGHG1///IGHD///IGHA1 → KLK3 (>>) |
| IGHV4-31///IGHV@///IGHM///IGHG1///IGHD///IGHA1 → IGKV4-1 (>>) |
| IGHV4-31///IGHV@///IGHM///IGHG1///IGHD///IGHA1 → TNFRSF17 (>>) |
| IGHV4-31///IGHV@///IGHM///IGHG1///IGHD///IGHA1 → RHAG (>>) |
| IGHV4-31///IGHV@///IGHM///IGHG1///IGHD///IGHA1 → OXCT2 (>>) |
| IGHV4-31///IGHV@///IGHM///IGHG1///IGHD///IGHA1 → SPG20 (>>) |
| IGHV4-31///IGHV@///IGHM///IGHG1///IGHD///IGHA1 → EFNA2 (>>) |
| IGHV4-31///IGHV@///IGHM///IGHG1///IGHD///IGHA1 → LOC652494///IGHM///IGHG3///IGHG1///IGHA1 (>>) |
